Cargando...
Essential thrombocythemia treatment algorithm 2018
Current drug therapy for myeloproliferative neoplasms, including essential thrombocythemia (ET) and polycythemia vera (PV), is neither curative nor has it been shown to prolong survival. Fortunately, prognosis in ET and PV is relatively good, with median survivals in younger patients estimated at 33...
Gardado en:
| Publicado en: | Blood Cancer J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5802626/ https://ncbi.nlm.nih.gov/pubmed/29321520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-017-0041-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|